Formulation & Product Development
Development of solid oral, liquid oral, semi-solid, complex generic, modified-release, and oral peptide formulations.
Research & Development
R&D is the cornerstone of Globtech Life Sciences' innovation-driven approach, supporting formulation development, analytical development, stability studies, technology transfer, and regulatory-ready pharmaceutical solutions.
Our R&D division supports development across solid oral, liquid oral, semi-solid, complex generic, modified-release, and oral peptide formulations.
The team works across formulation science, analytical methods, stability, pilot bio-batch support, technology transfer, and regulatory documentation to move products from concept to scalable execution.
Development of solid oral, liquid oral, semi-solid, complex generic, modified-release, and oral peptide formulations.
Analytical method development and validation, dissolution testing, physical and chemical testing, impurity profiling, and product characterization.
Stability programs to evaluate product integrity, shelf life, long-term performance, and ICH-aligned quality requirements.
Pilot-scale manufacturing, bio-batch preparation, and bioequivalence support to accelerate development timelines.
Efficient transfer of formulations from laboratory scale to commercial manufacturing with optimized scalability and reproducibility.
Regulatory documentation support for ANDA, 505(b)(2), CTD, ACTD, Para III, Para IV, and lifecycle submissions.
Specialized Expertise
Connect with the Globtech technical team for formulation strategy, analytical development, stability planning, and technology transfer support.
Contact Technical Team